Aducanumab Therapy Ameliorates Calcium Overload in a Mouse Model of Alzheimer's Disease

The limited number of treatment options has made Alzheimer's disease (AD) a challenging problem for clinicians and patients. Currently, there are five Food and Drug Administration-approved drugs for the management of AD. Four of these drugs are acetylcholinesterase inhibitors and the other is